Shewanella putrefaciens is a Gram-negative bacterium known for its metabolic versatility, particularly its ability to perform anaerobic respiration using a variety of electron acceptors . It is found in diverse environments, including marine sediments, soil, and even as an opportunistic pathogen in humans . S. putrefaciens is of interest in bioremediation, as it can reduce metals and other compounds .
Fumarate reductase is an enzyme that plays a crucial role in anaerobic respiration, specifically in the reduction of fumarate to succinate . In S. putrefaciens, a soluble fumarate reductase, flavocytochrome c, is produced under anaerobic conditions and shares sequence similarity with catalytic subunits of membrane-bound fumarate reductases from Escherichia coli and other bacteria . This enzyme is essential for fumarate respiration in vivo .
The fumarate reductase enzyme complex consists of several subunits, including the frdD subunit. The frdD subunit is a component of the membrane-bound fumarate reductase complex, which is responsible for anchoring the enzyme to the membrane . Recombinant frdD refers to the frdD subunit that has been produced using recombinant DNA technology, allowing for its isolation and study in vitro .
Flavocytochrome c3 is essential for fumarate respiration in vivo, as demonstrated by the specific loss of the ability to grow with fumarate as a terminal electron acceptor when the chromosomal fccA gene (encoding flavocytochrome c3) is disrupted .
Shewanella species, including S. putrefaciens, are emerging pathogens capable of causing severe infections, such as hepatobiliary, skin and soft tissue, gastrointestinal, and respiratory infections, as well as bacteremia . S. putrefaciens infections are often associated with underlying conditions such as hepatobiliary diseases, malignancy, chronic kidney disease, and diabetes mellitus .
Shewanella species can respire poorly soluble substrates using enzymatic machinery localized outside the cell . S. oneidensis strains MR-1 can engage in "extracellular respiration" of minerals and dimethyl sulfoxide (DMSO) .
Under cold stress conditions, S. putrefaciens exhibits significant changes in metabolic pathways, including down-regulation of chemotaxis and motility, and up-regulation of tryptophan metabolism, histidine biosynthesis, and quorum sensing, which benefit biofilm formation .
KEGG: spc:Sputcn32_0351
STRING: 319224.Sputcn32_0351
Fumarate reductase subunit D (frdD) is a membrane anchor component of the fumarate reductase enzyme complex in Shewanella putrefaciens. The complete enzyme typically consists of four subunits (A-D) and catalyzes the reduction of fumarate to succinate during anaerobic respiration. Specifically, frdD functions as one of the membrane-anchoring subunits that helps position the catalytic components appropriately within the cell membrane. This enzyme is critical for the organism's ability to use fumarate as a terminal electron acceptor during anaerobic respiration, which is particularly important in oxygen-limited environments that Shewanella species often inhabit .
The frdD protein from Shewanella putrefaciens (strain CN-32 / ATCC BAA-453) is relatively small, with an expression region spanning amino acids 1-121, and has a characteristic hydrophobic profile consistent with its membrane-associated function .
While the specific search results don't provide comparative data on frdD across different Shewanella species, research on Shewanella strains shows significant variation in genetic elements that may affect their pathogenicity and metabolic capabilities. Different strains of S. putrefaciens can exhibit pathogenic, saprophytic, or even probiotic characteristics .
For example, S. putrefaciens Pdp11 is described as a probiotic strain for use in aquaculture, while other strains have been associated with diseases in fish species such as common carp, rainbow trout, and eel . These functional differences are likely reflected in variations in metabolic enzymes, potentially including components of the fumarate reductase complex.
Optimal expression and purification of recombinant Shewanella putrefaciens frdD requires careful consideration of its membrane-associated nature. Based on the available information and standard practices for membrane proteins:
Expression System:
E. coli BL21(DE3) or similar strains are commonly used for recombinant membrane protein expression
Expression vectors containing T7 or similar strong inducible promoters
Inclusion of appropriate fusion tags (His-tag, GST, etc.) to facilitate purification while maintaining protein function
Expression Conditions:
Lower induction temperatures (16-25°C) to minimize inclusion body formation
Reduced inducer concentration (e.g., 0.1-0.5 mM IPTG) and extended expression times (overnight)
Supplementation with membrane-stabilizing agents (glycerol, specific detergents) may improve yields
Purification Strategy:
Cell membrane isolation by differential centrifugation
Solubilization using appropriate detergents (e.g., n-dodecyl-β-D-maltoside, CHAPS)
Affinity chromatography using the fusion tag
Size exclusion chromatography for final purification
Storage Conditions:
For the purified recombinant protein, recommended storage conditions include:
Storage buffer: Tris-based buffer containing 50% glycerol
Short-term storage: 4°C for up to one week
Long-term storage: -20°C or -80°C
Investigating protein-protein interactions within the fumarate reductase complex requires multiple complementary approaches:
Biochemical Approaches:
Co-immunoprecipitation (Co-IP) with antibodies specific to individual subunits
Pull-down assays using recombinant tagged subunits
Cross-linking studies followed by mass spectrometry to identify interaction interfaces
Analytical ultracentrifugation to study complex formation
Surface plasmon resonance (SPR) to measure binding kinetics
Structural Biology Techniques:
X-ray crystallography of the entire complex or subcomplexes
Cryo-electron microscopy to visualize the assembled complex
NMR studies of individual domains and their interactions
Hydrogen-deuterium exchange mass spectrometry to identify interacting regions
Computational Methods:
Molecular docking to predict interaction surfaces
Molecular dynamics simulations to study the dynamics of the complex
Sequence co-evolution analysis to identify potentially interacting residues
Functional Assays:
Site-directed mutagenesis of predicted interface residues followed by activity assays
Reconstitution experiments with purified subunits to measure assembly and enzymatic activity
Membrane incorporation studies to assess the role of frdD in complex anchoring
The fumarate reductase complex, including the frdD subunit, may play significant roles in both pathogenicity and environmental adaptation of Shewanella putrefaciens:
Pathogenicity Mechanisms:
Shewanella species have been identified as emerging pathogens causing various infections in humans and fish . While direct evidence linking frdD to pathogenicity is limited in the search results, anaerobic respiration capabilities are often critical for survival within host tissues. The fumarate reductase complex enables S. putrefaciens to:
Survive in oxygen-limited environments within host tissues
Generate energy under anaerobic conditions during infection
Potentially contribute to persistence during infection
Notably, research has shown that different strains of S. putrefaciens exhibit varying degrees of pathogenicity, with some strains causing infections in fish species including common carp, rainbow trout, and eel . This variability might be partially explained by differences in metabolic capabilities, potentially including variations in the fumarate reductase complex.
Environmental Adaptation:
Shewanella species are known for their remarkable respiratory versatility, which allows them to thrive in diverse environments:
Anaerobic respiration using fumarate as an electron acceptor allows survival in sediments and other oxygen-depleted environments
The membrane anchoring provided by frdD may be optimized for different environmental conditions
Variations in the fumarate reductase complex might contribute to the ability of different strains to occupy specific ecological niches
Research has demonstrated that some S. putrefaciens strains have probiotic properties while others are pathogenic or saprophytic , suggesting adaptive specialization that may involve differences in respiratory capabilities.
Assessing the functional activity of recombinant frdD requires specialized techniques due to its role as a membrane anchor rather than a catalytic subunit:
Membrane Incorporation Studies:
Liposome reconstitution with purified frdD to assess membrane integration
Fluorescence-based assays to measure protein orientation in membranes
Freeze-fracture electron microscopy to visualize membrane incorporation
Complex Assembly Assays:
In vitro reconstitution of the complete fumarate reductase complex using all purified subunits
Size exclusion chromatography to assess complex formation
Blue native PAGE to analyze intact complexes
Chemical cross-linking followed by SDS-PAGE to capture subunit interactions
Functional Activity Measurements:
Enzyme activity assays measuring fumarate to succinate conversion in reconstituted systems
Electron transfer measurements using artificial electron donors
Membrane potential measurements in proteoliposomes containing the reconstituted complex
Comparison of wild-type activity versus systems with modified or absent frdD
Structural Dynamics:
Hydrogen-deuterium exchange to monitor conformational changes
Electron paramagnetic resonance (EPR) spectroscopy to study the orientation of the complex in membranes
Fluorescence resonance energy transfer (FRET) to measure distances between subunits in the assembled complex
Designing effective mutation studies for frdD requires systematic approaches to identify and characterize functionally important residues:
Target Residue Identification:
Sequence conservation analysis across Shewanella species and other bacteria
Structural prediction to identify membrane-spanning regions and potential interaction surfaces
Hydrophobicity analysis to identify membrane-interacting regions
Comparison with known structures of homologous proteins from other organisms
Based on the sequence provided , potential targets include the highly hydrophobic regions consistent with transmembrane domains and the more polar regions that might interact with other subunits.
Mutation Strategy:
Alanine scanning of consecutive residues in predicted functional regions
Conservative substitutions (maintaining chemical properties) to refine functional understanding
Non-conservative substitutions to disrupt specific interactions
Introduction of reporter groups (e.g., cysteine residues for subsequent labeling)
Functional Analysis of Mutants:
Expression level and stability assessment
Membrane integration efficiency
Complex assembly capability with other subunits
Enzymatic activity of the reconstituted complex
In vivo complementation studies in frdD knockout strains
Data Analysis Framework:
Categorize mutations based on their effects (assembly defects vs. activity defects)
Correlate structural predictions with functional outcomes
Develop a comprehensive model of structure-function relationships
Iterative refinement of the model with targeted follow-up mutations
Recombinant frdD can serve as a valuable tool in comparative studies between different Shewanella strains with varying functional characteristics:
Comparative Genomics and Proteomics:
Research has demonstrated that Shewanella putrefaciens includes strains with distinct functional characteristics - some are pathogenic to fish species, others are saprophytic, and at least one strain (Pdp11) has been characterized as probiotic for use in aquaculture . Comparative studies can examine:
Sequence variations in the frdD gene and protein across strains
Expression levels of frdD under different growth conditions
Potential associations between frdD variants and strain pathogenicity or probiotic properties
Functional Comparisons:
Enzymatic activity assays comparing fumarate reductase function across strains
Growth characteristics under anaerobic conditions with fumarate as electron acceptor
Membrane composition and organization differences that might affect frdD function
Genetic Complementation:
Cross-complementation studies with frdD from different strains
Generation of chimeric frdD proteins to identify functional domains
Assessment of the impact of plasmid-encoded factors found in pathogenic strains on frdD function
While direct evidence linking frdD variations to the pathogenic/probiotic dichotomy is not presented in the search results, the documented differences between strains suggest that comparative studies of metabolic components like fumarate reductase could yield valuable insights.
Developing antibodies against frdD presents several challenges due to its nature as a membrane protein:
Challenges:
Limited immunogenicity of hydrophobic membrane-spanning regions
Difficulty in maintaining native conformation during immunization
Potential cross-reactivity with homologous proteins
Limited surface exposure in the assembled complex
Strategic Solutions:
| Approach | Methodology | Advantages | Limitations |
|---|---|---|---|
| Peptide antibodies | Synthesize immunogenic peptides from hydrophilic regions | Works with denatured protein, high specificity | May not recognize native protein |
| Recombinant fragments | Express soluble domains of frdD | Better folding, higher yield | May miss conformational epitopes |
| Full-length protein | Use detergent-solubilized purified protein | Recognizes native structure | Lower immunogenicity, technically challenging |
| Genetic immunization | DNA vaccines encoding frdD | In vivo expression with native folding | Variable expression levels |
Validation Methods:
Western blotting against recombinant protein and native complexes
Immunoprecipitation under native conditions
Immunofluorescence microscopy to confirm specificity
Cross-reactivity testing against homologous proteins from related species
Applications of Anti-frdD Antibodies:
Tracking expression levels under different growth conditions
Localization studies using immunofluorescence or immunogold electron microscopy
Co-immunoprecipitation to study protein-protein interactions
Potential therapeutic or diagnostic applications in Shewanella infections
Understanding the evolutionary and functional relationships between frdD in Shewanella putrefaciens and homologous proteins in other bacteria provides important context:
Evolutionary Conservation:
The fumarate reductase complex is found in many facultative and anaerobic bacteria, though with variations in subunit composition and structural organization. Comparative analysis can reveal:
Degree of sequence conservation in the membrane anchor subunits
Evolutionary adaptations to different environmental niches
Structural variations that might impact function
Functional Comparisons:
Activity comparisons under standardized conditions
Substrate specificity differences
Regulatory mechanisms controlling expression
Environmental factors affecting enzymatic performance
Cross-Species Complementation:
Ability of frdD from different species to functionally substitute for each other
Identification of species-specific interactions with other subunits
Adaptation to different membrane compositions
Model Organisms for Comparison:
Escherichia coli - well-characterized fumarate reductase system
Other Shewanella species with different environmental adaptations
Pathogenic bacteria where fumarate reductase contributes to virulence
Extremophiles with adaptations to harsh environmental conditions
The study of recombinant Shewanella putrefaciens frdD offers several promising research avenues:
Structure-Function Relationships:
High-resolution structural studies of the complete fumarate reductase complex
Investigation of conformational changes during catalytic activity
Detailed mapping of interaction surfaces between subunits
Biotechnological Applications:
Development of biosensors based on the electron transport capabilities
Engineering of fumarate reductase for biocatalysis applications
Potential use in microbial fuel cells and bioremediation
Medical and Environmental Applications:
Investigation of frdD as a potential antibiotic target for Shewanella infections
Study of fumarate reductase inhibitors as potential antimicrobials
Exploration of the role of frdD in environmental adaptations relevant to bioremediation
Comparative Microbiology:
Extended studies across Shewanella strains with different functional characteristics
Investigation of horizontal gene transfer and evolutionary history of frdD
Broader ecological studies on the role of anaerobic respiration in environmental adaptation
Research into Shewanella species has clinical relevance, as they have been identified as emerging pathogens worldwide, associated with both community- and hospital-acquired infections . Understanding the metabolic capabilities that enable their pathogenicity, including anaerobic respiration, could contribute to improved treatment strategies.
Bioinformatics approaches offer powerful tools for investigating frdD structure, function, and evolution:
Sequence Analysis:
Identification of conserved domains and functional motifs
Prediction of transmembrane regions and protein topology
Evolutionary analysis through multiple sequence alignments
Detection of selective pressure on specific regions
Structural Prediction:
Homology modeling based on related structures
Ab initio modeling of unique regions
Prediction of protein-protein interaction surfaces
Molecular dynamics simulations of membrane integration
Functional Prediction:
Identification of potentially critical residues for function
Prediction of post-translational modifications
Metabolic pathway analysis and flux modeling
Analysis of gene neighborhood and potential operonic structures
Integrative Approaches:
Integration of -omics data to understand regulation and expression
Network analysis of protein-protein interactions
Systems biology modeling of anaerobic respiration
Comparative genomics across Shewanella strains with different characteristics